Drugs / Danshen Dripping Pill
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06727890 | Jan 2025 → Dec 2026 expected | coronary microvascular disorder | Qilu Hospital of Shandong University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT01825759 | Jan 2013 → Dec 2014 | coronary artery disorder, essential hypertension | West China Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danshen Dripping Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06727890 ↗ |
| Route | Oral | “by mouth” NCT01825759 ↗ |